The 5 most interesting analyst questions from 10x Genomics’s Q1 earnings call

IlluminaCorvex Funds tied to Illumina (NASDAQ: ILMN) sell shares and partly unwind equity swaps - Stock Titan

FierceBiotechChutes & Ladders—AC Immune CEO bids adieu

Clinical OMICsAI in Healthcare: Symposium Insights

FierceBiotechSignant Health buys Ametris to unite data streams in clinical trials

ScienceDid this scientist go too far trying to save Ecuador’s wildlife?

Endpoints NewsEncoded's gene therapy reduced seizures in Dravet syndrome

Clinical OMICsA Retina’s Biological Age Can Predict Osteoporosis Risk

Clinical OMICsWireless Stress Detector Offers Multiple Medical Uses

Endpoints NewsASGCT dispatch: In vivo CAR-T is everywhere, but still preclinical

Clinical OMICsPrior Heart Attack Linked to Faster Cognitive Decline Over Time

BioPharma DiveCreate Medicines raises $122M to bolster in vivo CAR-T therapies

FierceBiotechBioAge CEO has big plans for 'multi-disease impact' of NLRP3 drug across cardio, ocular and CNS